Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report kblankenship Mon, 10/19/2020 – 08:33
Don’t tell me, you’ve taken up ornithology?No, not yet. In fact, this is a political term that is […]
Galcanezumab, a new migraine drug, has been recommended by the National Institute for Health and Care Excellence as […]
Over 1400 general practice registrars in Australia are being forced to re-sit their fellowship exams after the online […]
The analysis by Tzortziou Brown and colleagues says it all1—the proposal to reintroduce appraisal and revalidation is ill […]
Following completion of acquisition, site will undergo refurbishment
FDA approved therapy for newly-diagnosed acute myeloid leukaemia patients
Chief executive of trade body warns no-deal could affect medicines supply
Dupixent, Forxiga and Opdivo were also recommended for therapeutic extensions
